Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvsef crawled date : 2022 - 07 - 25 save search
Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-07-25 (Crawled : 20:00) - prnewswire.com
AZNCF | $138.24 800
|
Health Technology
|
| O: 3.39%
H: 0.42%
C: -1.6%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.96%
H: 0.47%
C: -0.08%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: -0.17%
H: 0.48%
C: 0.17%
ABBV | News | $165.97 0.8% 3.1M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
AZN | $68.41 0.07% 2.9M
|
Health Technology
|
| O: 0.62%
H: 1.09%
C: 0.23%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.37%
H: 1.66%
C: 0.6%
drug global market
Global Topical Drug Delivery Market Report to 2027 - Featuring Nestle, GlaxoSmithKline and Novartis Among Others
Published: 2022-07-25 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
TARO | $42.31 0.28% 7.4K
|
Health Technology
|
| O: 0.08%
H: 3.37%
C: -1.86%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
GSK | $39.585 0.8% 1.1M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
drug global report novartis market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-07-25 (Crawled : 06:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
GSK | $39.585 0.8% 1.1M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
ADCT | $4.72 -0.84% 190K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -2.31%
ABBV | News | $165.97 0.8% 3.1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -7.8%
H: 3.72%
C: 2.37%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.37%
H: 0.9%
C: 0.75%
therapeutics market
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
Published: 2022-07-25 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
fda biosimilar ema sclerosis multiple sclerosis
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.